Document is current

Article History

Received: 21 July 2025

Accepted: 21 November 2025

First Online: 26 November 2025

Declarations

:

: Ethics approval was obtained for the ePRO ancillary study conducted within DOPPS phase 7 (2021–2023), in accordance with the Declaration of Helsinki and relevant local regulations. All participants provided additional informed consent prior to enrollment and completion of quarterly questionnaires.

: Not applicable.

: JF has received research funding from CSL-Vifor, AstraZeneca and Boehinger-Ingelheim, in addition to funding from the National Institute of Health Research into outcomes for people on dialysis.CT, RP, SF, and AK are employees of Arbor Research Collaborative for Health, which administers the DOPPS. All funds are made to Arbor Research Collaborative for Health and not directly to the authors.RPF reports: Honoraria (paid to employer) from Astra Zeneca, Boehringer-Lilly, Akebia, Bayer, GSK, Novo Nordisk for participation in Advisory Boards and educational activities. Consulting fees Scientific Leadership in clinical trials from the George Clinical. Research grants from Fresenius Medical Care, National Council for Scientific and Technological Development. RPF is employed by Arbor Research Collaborative for health, who runs the DOPPS studies. Global support for the ongoing DOPPS Programs is provided without restriction on publications by a variety of funders. Funding is provided to Arbor Research Collaborative for Health and not to RPF. For details see https://www.dopps.org/AboutUs/Support.aspx. DR is an employee of CSL Vifor, and TS was an employee of CSL Vifor at the time the manuscript was developed.MV has received research support from Fresenius Medical Care, CSL Vifor, Admesy, Calciscon AG, Astra-Zeneca, Dutch Kidney Foundation, Dutch Ministry of Economics (Health Holland) (all to institution); participated in advisory boards for Astra-Zeneca, Boehringer Ingolheim, Kyowa Kirin, CSL Vifor (fees all to institution); and participated in committees: KDIGO executive committee; KDIGO subcommittee on CKD-MBD, Advisory board Dutch ministry of health (all unpaid).